Development of gastroretentive fibrous dosage form for prolonged delivery of sparingly-soluble tyrosine kinase inhibitors

• Unité de recherche: INNOSUISSE
• Numéro de projet: 106.127.1 IP-LS
• Titre du projet anglais: Development of gastroretentive fibrous dosage form for prolonged delivery of sparingly-soluble tyrosine kinase inhibitors

Description succincte (Allemand)

Development of gastroretentive fibrous dosage form for prolonged delivery of sparingly-soluble tyrosine kinase inhibitors

Description succincte (Anglais)

Development of gastroretentive fibrous dosage form for prolonged delivery of sparingly-soluble tyrosine kinase inhibitors

Résumé des résultats (Abstract) (Allemand)

We propose the development of a gastroretentive dosage form for prolonged delivery of sparingly-soluble tyrosine kinase inhibitors. It is hoped that the dosage form will enable to maintain a steady drug concentration in blood for enhancing efficacy and reducing side effects of cancer therapies.

Résumé des résultats (Abstract) (Anglais)

We propose the development of a gastroretentive dosage form for prolonged delivery of sparingly-soluble tyrosine kinase inhibitors. It is hoped that the dosage form will enable to maintain a steady drug concentration in blood for enhancing efficacy and reducing side effects of cancer therapies.